Our favorite healthcare economist, Jason Shafrin, has a very topical round-up of the fall-out from the recent Komen/PP/HHS kerfluffle. As usual, his 'Review is well-organized, compelling and eclectic.
Enjoy!
Enjoy!
Popular Posts
-
The drug, a generic version of Lipitor), is being recalled by its manufacturer. From Medical Mutual email: " Ranbaxy... has announced a...
-
This just in from (a major health insurance carrier) and we are passing it along. I believe they want their agents to feel warm and fuzzy. ...
-
Next week, we're proud to once again host the Health Wonk Review , the bi-weekly roundup of health care policy and polity. Please submit...
-
Obamacare. The master plan to deliver (almost) universal access to health care for everyone. Promises of lower premiums. Promises that you c... -
Unusual and Interesting Insurance News - Over the years , we've chronicled such things as virginity and alien abduction insurance (dif...
-
Nina Kallen makes her CavRisk hosting debut next Wednesday (December 1). Submissions are due this Monday (the 29th). Please remember to i...
-
■ First up, FoIB Jeff M tips us to this rather sorry Tar Heel State of affairs: " [North Carolina] one of the least competitive health...
-
From the Telegraph of London on 9/11: " Death rates in NHS hospitals are among the highest in the western world , shock figures reveal...
-
We're pleased as punch to once again host the Health Wonk Review. Submissions are due by next Wednesday (the 9th), and once again we...
-
In honor of Life Insurance Awareness Month , we'll be stepping up our postings on this valuable, but often neglected, coverage. In addit...
0 komentar:
Posting Komentar